Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis

Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis

Liquid biopsy based on circulating cell-free DNA (cfDNA) is a promising non-invasive tool for the prognosis of hepatocellular cancer (HCC). In this exploratory study we investigated whether cfDNA and gene variants associated with HCC may be found in patients with liver cirrhosis (LC) and thus identi...

Full description

Bibliographic Details
Main Authors:	Marianna Alunni-Fabbroni, Sabine Weber, Osman Öcal, Max Seidensticker, Julia Mayerle, Peter Malfertheiner, Jens Ricke
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Cancers
Subjects:	liver cirrhosis MRI HCC liquid biopsy circulating cell-free DNA
Online Access:	https://www.mdpi.com/2072-6694/13/3/521

Similar Items

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
by: Marianna Alunni-Fabbroni, et al.
Published: (2019-10-01)

NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial
by: Thomas Geyer, et al.
Published: (2021-06-01)

Diagnostic accuracy of serum endothelin-1 in patients with HCC on top of liver cirrhosis
by: Mohammad M. Elbadry, et al.
Published: (2020-06-01)

Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) in alcoholic cirrhosis
by: Moiz Ahmed, et al.
Published: (2021-03-01)

Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy
by: Matthias Stechele, et al.
Published: (2023-07-01)

Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis
by: M. V. Chistyakova, et al.
Published: (2019-05-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01)

HCC or Something Else? Frequency of Various Benign and Malignant Etiologies in Cirrhotic Patients with Newly Detected Focal Liver Lesions in Relation to Different Clinical and Sonographic Parameters
by: Amjad Alhyari, et al.
Published: (2022-08-01)

CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC
by: Lukas Salvermoser, et al.
Published: (2024-05-01)

High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities
by: Jan-Hendrik Bockmann, et al.
Published: (2021-04-01)

Single-cell RNA sequencing reveals the mediatory role of cancer-associated fibroblast PTN in hepatitis B virus cirrhosis-HCC progression
by: Chenhong Lin, et al.
Published: (2023-05-01)

Circulating Cytokines Reflect the Etiology-Specific Immune Environment in Cirrhosis and HCC
by: Boris J. B. Beudeker, et al.
Published: (2022-10-01)

Role of Fibroscan for early detection of hepatocellular carcinoma (HCC) in hepatitis C cirrhotic patients
by: Ahmed Elhosieny Ebrahim, et al.
Published: (2020-07-01)

The short-term efficacy of no-touch radiofrequency ablation in treating cirrhosis-based small hepatocellular carcinoma
by: Yuelong Chai, et al.
Published: (2019-05-01)

Pre-Transplant Alpha-Fetoprotein > 25.5 and Its Dynamic on Waitlist Are Predictors of HCC Recurrence after Liver Transplantation for Patients Meeting Milan Criteria
by: Bianca Magro, et al.
Published: (2021-11-01)

Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study
by: Filomena Morisco, et al.
Published: (2021-07-01)

HCC: RNA-Sequencing in Cirrhosis
by: Haoyu Wang, et al.
Published: (2023-01-01)

Factors associated with recurrence and survival in liver transplant patients with HCC - a single center retrospective study
by: Sergio Hoyos, Dr., et al.
Published: (2015-01-01)

Contrast Enhanced MRI in the Diagnosis of HCC
by: Eric Niendorf, et al.
Published: (2015-09-01)

Ductular reaction or hepatic reparative complex: immunohistochemical features in liver cirrhosis in patients with chronic hepatitis
by: V. A. Tumanskiy, et al.
Published: (2018-04-01)

Multi-phasic magnetic resonance imaging of hemodynamic interchanges in hepatocarcinogenesis
by: Ahmed Mahmoud Elzeneini, et al.
Published: (2023-10-01)

HCC portal hypertension imaging score derived from CT predicts re-bleeding and mortality after acute variceal bleeding
by: Mingyuan Zhao, et al.
Published: (2024-03-01)

Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study
by: Luca Rinaldi, et al.
Published: (2019-08-01)

A Novel Pathological Scoring System for Hepatic Cirrhosis with Hepatocellular Carcinoma
by: Dong W, et al.
Published: (2020-07-01)

Safe standard remnant liver volume after hepatectomy in HCC patients in different stages of hepatic fibrosis
by: Zhiming Zhang, et al.
Published: (2021-01-01)

Preliminary results of retrospective analysis Atezolizumab and Bevacizumab in first-line therapy of advanced HCC
by: I. А. Dzhanyan, et al.
Published: (2021-06-01)

Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma
by: Timothy Block, et al.
Published: (2022-12-01)

Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population
by: Kepu Zheng, et al.
Published: (2023-07-01)

Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score
by: Thai Ngoc Truong, et al.
Published: (2023-09-01)

Stability and Reproducibility of Radiomic Features Based Various Segmentation Technique on MR Images of Hepatocellular Carcinoma (HCC)
by: Nurin Syazwina Mohd Haniff, et al.
Published: (2021-08-01)

Cardiovascular changes in cirrhosis: Pathogenesis and clinical implications
by: Al-Hamoudi Waleed
Published: (2010-01-01)

MicroRNAs as Plasma Biomarkers of Hepatocellular Carcinoma in Patients with Liver Cirrhosis—A Cross-Sectional Study
by: Robin Zenlander, et al.
Published: (2024-02-01)

Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature
by: Di Carlo Isidoro, et al.
Published: (2012-05-01)

Management of Hepatocellular Carcinoma in Decompensated Cirrhotic Patients: A Comprehensive Overview
by: Maria Tampaki, et al.
Published: (2023-02-01)

Additive role of dynamic subtraction MRI in assessment of unresolved HCC post-radiofrequency ablation
by: Hany El-Assaly, et al.
Published: (2021-10-01)

Elevated Serum Vinculin in Patients with HBV/HCV-Associated Liver Cirrhosis and Hepatocellular Carcinoma: A Pilot Study
by: Essa A, et al.
Published: (2023-03-01)

Role of bile acids in the prediction of hepatocellular carcinoma in HCV-induced liver cirrhosis
by: Ashraf Khalil, et al.
Published: (2021-09-01)

Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC)
by: Taehee Lee, et al.
Published: (2022-04-01)

Role of DWI in evaluation of HCC after radiofrequency ablation compared to dynamic MRI using MRI (3 T)
by: Bahaa Mohamed Elrefaey Hasan, et al.
Published: (2021-11-01)